Archer Daniels Midland
ADM
$72.80
+3.20%
Archer Daniels Midland (ADM) is a global agricultural processor and commodity trader, operating in the Agricultural Farm Products industry. The company's core activities include processing oilseeds, corn, and wheat, merchandising grain through its vast logistical network, and producing ingredients for human and animal nutrition, sweeteners, starches, and ethanol. As a dominant player and market leader in global agricultural supply chains, ADM's competitive identity is defined by its massive scale, integrated global asset network, and diversification across agricultural commodities and value-added products. The current investor narrative is heavily focused on the company's recovery from a period of weak earnings and its ongoing operational turnaround, as recent quarterly results show a significant year-over-year decline in revenue, pressuring the stock despite a strong one-year price performance that suggests the market is anticipating a fundamental rebound.…
ADM
Archer Daniels Midland
$72.80
ADM 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Archer Daniels Midland's 12-month outlook, with a consensus price target around $94.64 and implied upside of +30.0% versus the current price.
Average Target
$94.64
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$58 - $95
Analyst target range
Analyst coverage for ADM is currently limited, with only 3 analysts providing estimates according to the data. This sparse coverage, for a company of ADM's size, is unusual and may indicate reduced institutional focus or heightened uncertainty following its recent challenges. The consensus recommendation is not explicitly provided in the data, but the institutional ratings show a cautious stance, with recent actions from JP Morgan (Underweight), Barclays (Equal Weight), and Morgan Stanley (downgrading to Underweight). The average revenue estimate for the coming period is $84.61 billion, with a wide range from $80.15 billion to $98.16 billion, indicating significant divergence in views on the top-line recovery. The average EPS estimate is $3.97, with a range from $3.70 to $4.80. The wide target spread on both revenue and EPS signals high uncertainty among analysts regarding the pace and magnitude of ADM's operational turnaround, which can contribute to stock price volatility.
Bulls vs Bears: ADM Investment Factors
The investment debate for ADM centers on the timing and magnitude of its earnings recovery versus the reality of severe current fundamental weakness. The bull case is supported by a pristine balance sheet, a low forward P/E implying a sharp profit rebound, and strong long-term momentum. The bear case is grounded in stark revenue declines, collapsing margins, and a high trailing P/E that leaves no margin for disappointment. Currently, the bear side holds stronger evidence, as the stock's recent price appreciation appears to have run ahead of deteriorating fundamentals, creating a valuation gap. The single most important tension is whether ADM can deliver on the analyst consensus of $3.97 in forward EPS to justify its current price, or if continued margin pressure will lead to another round of earnings downgrades and multiple compression.
Bullish
- Strong Balance Sheet & Low Leverage: ADM maintains a fortress balance sheet with a debt-to-equity ratio of 0.37 and a current ratio of 11.2, indicating minimal financial risk and ample liquidity. This financial strength provides a buffer against commodity market volatility and funds a stable dividend, with a yield of 3.55%.
- Analysts Project Sharp EPS Recovery: The forward P/E of 14.17x is based on an average analyst EPS estimate of $3.97, implying a significant earnings rebound from the recent quarterly EPS of $0.94. This projected 322% increase in EPS underpins the market's expectation of a successful operational turnaround.
- Robust Long-Term Price Momentum: The stock has delivered a 41.92% return over the past year, significantly outperforming the S&P 500 by 11.33 percentage points. This strong momentum suggests the market is pricing in a recovery, with the price trading at 93% of its 52-week high of $74.19.
- Defensive, Low-Beta Profile: With a beta of 0.636, ADM is approximately 36% less volatile than the broader market, offering a defensive characteristic. This makes the stock potentially more resilient during broader market downturns, appealing to risk-averse investors.
Bearish
- Severe Revenue & Profit Compression: Q4 2025 revenue declined 13.68% YoY to $18.56B, with net margin collapsing to 2.46% from 5.67% a year ago. This multi-quarter contraction in both top and bottom lines reflects intense pressure from normalized commodity prices and weak processing margins.
- Elevated Trailing P/E Priced for Perfection: The trailing P/E of 25.81x is elevated for a commodity processor, especially given the depressed earnings. This valuation suggests the market has already priced in a substantial recovery, leaving little room for error and high vulnerability to earnings misses.
- Recent Technical Divergence & Underperformance: The stock is down 3.39% over the past month, underperforming the S&P 500 by 12.09 percentage points, signaling the powerful uptrend is stalling. Trading near the 52-week high resistance of $74.19 increases the risk of a technical pullback.
- Sparse Analyst Coverage & Institutional Skepticism: Only 3 analysts provide estimates, indicating reduced institutional focus, and recent ratings include Underweight from JP Morgan and Morgan Stanley. The wide EPS estimate range ($3.70 to $4.80) reflects high uncertainty about the turnaround's success.
ADM Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a robust 41.92% one-year price appreciation. Currently trading at $69.23, the price sits near the top of its 52-week range of $46.81 to $74.19, approximately 93% of the way towards the high, indicating strong momentum but also potential overextension and vulnerability to a pullback from resistance. The short-term momentum, however, has diverged negatively from the longer-term trend, with the stock down 3.39% over the past month and up only 2.55% over the past three months, suggesting the powerful uptrend is losing steam and entering a consolidation phase. This divergence is further emphasized by a negative 1-month relative strength of -12.09 versus the S&P 500, indicating significant underperformance in the recent period. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $74.19 and support at the 52-week low of $46.81. A decisive breakout above $74.19 would signal a resumption of the primary bull trend, while a failure here could lead to a deeper retracement. The stock's beta of 0.636 indicates it is approximately 36% less volatile than the broader market, which is typical for a large-cap defensive name but also suggests its recent underperformance is more idiosyncratic than market-driven.
Beta
0.64
0.64x market volatility
Max Drawdown
-13.4%
Largest decline past year
52-Week Range
$47-$74
Price range past year
Annual Return
+51.5%
Cumulative gain past year
| Period | ADM Return | S&P 500 |
|---|---|---|
| 1m | +0.8% | +12.2% |
| 3m | +8.0% | +2.3% |
| 6m | +20.0% | +4.7% |
| 1y | +51.5% | +29.2% |
| ytd | +23.3% | +4.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ADM Fundamental Analysis
ADM's revenue trajectory shows clear signs of pressure, with the most recent Q4 2025 revenue of $18.56 billion representing a 13.68% year-over-year decline. Sequentially, revenue has trended downward from $21.47 billion in Q1 2024, indicating a multi-quarter contraction, largely driven by normalization in agricultural commodity prices and volumes. The Ag Services and Oilseeds segment, which generated $14.01 billion in the latest period, remains the dominant revenue driver, but its performance is tied to volatile global crop markets. Profitability remains positive but compressed; Q4 2025 net income was $456 million, yielding a net margin of 2.46%, a significant drop from the 5.67% net margin in the year-ago quarter. The gross margin for Q4 2025 was 6.54%, which is low for the industry and reflects the thin, volatile margins inherent in commodity processing and trading. The balance sheet and cash flow position is a relative strength, with a strong current ratio of 11.2 and a conservative debt-to-equity ratio of 0.37, indicating low financial leverage. However, operating cash flow was negative $313 million in the latest quarter, though trailing-twelve-month free cash flow remains a healthy $4.20 billion, providing ample liquidity for dividends and investments. The return on equity of 4.74% is modest, reflecting the current period of compressed earnings power.
Quarterly Revenue
$18.6B
2025-12
Revenue YoY Growth
-0.13%
YoY Comparison
Gross Margin
+0.06%
Latest Quarter
Free Cash Flow
$4.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ADM Overvalued?
Given ADM's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio is elevated at 25.81x, while the forward P/E is substantially lower at 14.17x. This wide gap implies the market is pricing in a significant recovery in earnings, aligning with analyst EPS estimates averaging $3.97 for the coming period, a sharp increase from the recent quarterly EPS of $0.94. Compared to the broader Consumer Defensive sector, ADM's trailing P/E of 25.81x likely trades at a premium, though specific industry average data is not provided; this premium would need to be justified by a return to historical profitability levels. Historically, ADM's own P/E ratio has fluctuated significantly, as seen in the provided data ranging from a low near 10.65x in late 2024 to highs above 66x during periods of depressed earnings in 2025. The current trailing P/E of 25.81x sits above the middle of this recent historical range, suggesting the market has already priced in a meaningful portion of the expected earnings recovery, leaving less margin for error.
PE
25.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 9x~400x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are centered on earnings volatility and valuation dependency. ADM's net margin compressed from 5.67% to 2.46% year-over-year in Q4 2025, and revenue declined 13.68%, demonstrating high sensitivity to commodity cycles. The company's valuation is entirely dependent on a projected earnings recovery, with a forward P/E of 14.17x requiring EPS to surge from $0.94 to nearly $4.00. A failure to achieve this would cause significant multiple compression from the current elevated trailing P/E of 25.81x. Furthermore, the negative operating cash flow of -$313M in the latest quarter, despite strong TTM FCF, signals potential near-term liquidity strain if the downturn persists.
Market & Competitive Risks include valuation compression and sector rotation. Trading at 93% of its 52-week high with a trailing P/E of 25.81x, ADM is vulnerable to a pullback if growth expectations are not met. Its low beta of 0.636 offers defensive characteristics but also means it may not participate fully in market rallies, as evidenced by its recent 12.09% underperformance versus the S&P 500 over the past month. Competitive and regulatory pressures in global agriculture could further squeeze already thin gross margins of 6.54%. The sparse analyst coverage (only 3 analysts) and institutional downgrades (e.g., Morgan Stanley to Underweight) reflect a skeptical market sentiment that could limit upside.
Worst-Case Scenario involves a 'double miss' on both earnings and sentiment. A combination of sustained weak commodity prices, operational missteps, and a broader market risk-off event could trigger a cascade of analyst downgrades. This would compress the forward P/E multiple towards historical lows while also lowering EPS estimates, leading to a severe price decline. The realistic downside could see the stock re-test its 52-week low of $46.81, representing a potential loss of approximately -32% from the current price of $69.23. A more probable adverse scenario, aligning with the lower end of analyst estimates and a de-rating, could see a decline of -20% to the mid-$50s.